T cell suppression as a mechanism for tolerance to MUC1 antigen in MUC1 transgenic mice (original) (raw)
References
Boon T, van der Bruggen P: Human tumor antigens recognized by T lymphocytes. J Exp Med 183: 725–729, 1996 Google Scholar
Goodnow CC: Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc Natl Acad Sci USA 93: 2264–2271, 1996 Google Scholar
Guerder S, Meyerhoff J, Flavell R: The role of the T cell costimulator B7–1 in autoimmunity and the induction and maintenance of tolerance to peripheral antigen. Immunity 1: 155–166, 1994 Google Scholar
Harding FA, McArthur JG, Gross JA, Raulet DH, Allison JP: CD28-mediated signaling co-stimulates murine T cells and prevents induction of anergy in T cell clones. Nature 356: 607–609, 1992 Google Scholar
Speiser DE, Miranda R, Zakarian A, Bachmann MF, McKall-Faienza K, Odermatt B, Hanahan D, Zinkernagel RM, Ohashi PS: Self antigens expressed by solid tumors do not efficiently stimulate naive or activated T cells: Implications for immunotherapy. J Exp Med 186: 645–653, 1997 Google Scholar
Kurts C, Kosaka H, Carbone FR, Miller JF, Heath WR: Class Irestricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8+ T cells. J ExpMed 186: 239–245, 1997 Google Scholar
Wei C, Willis RA, Tilton BR, Looney RJ, Lord EM, Barth RK, Frelinger JG: Tissue-specific expression of the human prostate-specific antigen gene in transgenic mice: implications for tolerance and immunotherapy. Proc Natl Acad Sci USA 94: 6369–6374, 1997 Google Scholar
Kufe D, Inghirami G, Abe M, Hayes D, Justi-Wheeler H, Schlom J: Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. Hybridoma 3: 223–232, 1984 Google Scholar
Perey L, Hayes DF, Maimonis P, Abe M, O'Hara C, Kufe DW: Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigen. Cancer Res 52: 2563–3568, 1992 Google Scholar
Jerome KR, Barnd DL, Bendt KN, Boyer CM, Taylor-Papdimitriou J, McKenzie IFC, Bast RC Jr, Finn OJ: Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res 51: 2908–2916, 1991 Google Scholar
Kirii Y, Nagarian-Blander J, Alter ND, Kotera Y, Finn OJ: Functional and molecular analysis of T cell receptors used by pancreatic-and breast tumor-(mucin-) specific cytotoxic T cells. J Immunother 21: 188–197, 1998 Google Scholar
Rowse GJ, Tempero RN, VanLith ML, Hollingsworth MA, Gendler SJ: Tolerance and immunity to MUC1 in a human MUC1 transgenic murine model. Cancer Res 58: 315–321, 1998 Google Scholar
Tempero RN, Vanlith NL, Morikane K, Rowse GJ, Gendler SJ, Hollingsworth NA: CD4+ lymphocytes provide MUC1-specific tumor immunity in vivo that is undetectable in vitro and is absent in MUC1 transgenic mice. J Immunology 161: 5500–5506, 1998 Google Scholar
Peat N, Gendler SJ, Lalani E-N, Duhig T, Taylor-Papadimitriou J: Tissue-specific expression of a human polymorphic epithelial mucin (MUC1) in transgenic mice. Cancer Res 52: 1954–1960, 1992 Google Scholar
Akagi J, Hodge JV, McLaughlin JP, Fritz L, Panicali D, Kufe D, Schlom J, Kantor JA: Therapeutic antitumor response after immunization with an admixture of recombinant vaccinia viruses expressing a modified MUC1 gene and the murine T-cell costimulatory molecule B7. J Immunotherapy 20: 38–47, 1997 Google Scholar
Siddiqui J, Abe M, Hayes D, Shani E, Yunis E, Kufe D: Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen. Proc Natl Acad Sci USA 85: 2320–2323, 1988 Google Scholar
Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cells death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493–501, 1992 Google Scholar
Heath WR, Kurts C, Miller JFAP, Carbone FR: Crosstolerance: a pathway for inducing tolerance to peripheral tissue antigens. J Exp Med 187: 1549–1553, 1998 Google Scholar
Hammerling GJ, Schonrich G, Ferber I, Arnold B: Peripheral tolerance as a multi-step mechanism. Immunol Rev 133: 93–104, 1993 Google Scholar
Burnet FN: The Clonal Selection Theory of Acquired Immunity. Nashville, TN: Vanderbilt University Press, 1959 Google Scholar
Gong J, Chen D, Kufe D: Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells. Nature Med 3: 558–561, 1997 Google Scholar
Gong J, Chen D, Kashiwaba N, Li Y, Takeuchi H, Qu H, Rowse GJ, Gendler SJ, Kufe DW: Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells. Proc Natl Acad Sci USA 95: 6279–6283, 1998 Google Scholar
Gimmi CD, Morrison BW, Mainprice BA, Boussiotis VA, Gribben JG, Freeman GJ, Hayes DF, Park SL, Kufe DW, Nadler LN: Breast cancer associated antigen, DF3/MUC1, induces apoptosis of activated human T cells. Nature Med 2: 1367–1370, 1996 Google Scholar
Agrawal B, Krantz NJ, Reddish MA, Longenecker BM: Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2. Nature Medicine 4: 43–49, 1998 Google Scholar
Schwartz RH: A cell culture model for T lymphocyte clonal anergy. Science 248: 1349, 1990 Google Scholar